These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 11956604)
1. Internalisation and retention of EGF-dextran associated radioactivity in transfected Chinese hamster ovary cells expressing the human EGF-receptor. Olsson P; Collins VP; Liu L; Gedda L; Liljegren A; Carlsson J Int J Oncol; 2002 May; 20(5):1057-63. PubMed ID: 11956604 [TBL] [Abstract][Full Text] [Related]
2. Uptake of a boronated epidermal growth factor-dextran conjugate in CHO xenografts with and without human EGF-receptor expression. Olsson P; Gedda L; Goike H; Liu L; Collins VP; Pontén J; Carlsson J Anticancer Drug Des; 1998 Jun; 13(4):279-89. PubMed ID: 9627668 [TBL] [Abstract][Full Text] [Related]
3. Penetration and binding of epidermal growth factor-dextran conjugates in spheroids of human glioma origin. Lindström A; Carlsson J Cancer Biother; 1993; 8(2):145-58. PubMed ID: 7528598 [TBL] [Abstract][Full Text] [Related]
4. EGF and dextran-conjugated EGF induces differential phosphorylation of the EGF receptor. Hägg M; Liljegren A; Carlsson J; Rönnstrand L; Lennartsson J Int J Mol Med; 2002 Nov; 10(5):655-9. PubMed ID: 12373311 [TBL] [Abstract][Full Text] [Related]
5. Internalization and excretion of epidermal growth factor-dextran-associated radioactivity in cultured human squamous-carcinoma cells. Olsson P; Lindström A; Carlsson J Int J Cancer; 1994 Feb; 56(4):529-37. PubMed ID: 7509322 [TBL] [Abstract][Full Text] [Related]
6. Binding, internalization and excretion of TGF alpha-dextran associated radioactivity in cultured human glioma cells. Lövqvist A; Lindström A; Carlsson J Cancer Biother; 1993; 8(4):345-56. PubMed ID: 7528599 [TBL] [Abstract][Full Text] [Related]
7. Binding of epidermal growth factor-dextran conjugates to cultured glioma cells. Andersson A; Holmberg A; Carlsson J; Carlsson J; Pontén J; Westermark B Int J Cancer; 1991 Feb; 47(3):439-44. PubMed ID: 1704355 [TBL] [Abstract][Full Text] [Related]
8. Development and in vitro studies of epidermal growth factor-dextran conjugates for boron neutron capture therapy. Gedda L; Olsson P; Pontén J; Carlsson J Bioconjug Chem; 1996; 7(5):584-91. PubMed ID: 8889021 [TBL] [Abstract][Full Text] [Related]
9. Binding, internalization and degradation of EGF-dextran conjugates in two human bladder-cancer cell lines. Sjöström A; Bue P; Malmström PU; Nilsson S; Carlsson J Int J Cancer; 1997 Feb; 70(4):383-9. PubMed ID: 9033643 [TBL] [Abstract][Full Text] [Related]
10. Cellular retention of radioactivity and increased radiation dose. Model experiments with EGF-dextran. Sundberg AL; Blomquist E; Carlsson J; Steffen AC; Gedda L Nucl Med Biol; 2003 Apr; 30(3):303-15. PubMed ID: 12745022 [TBL] [Abstract][Full Text] [Related]
11. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas. Barth RF; Yang W; Adams DM; Rotaru JH; Shukla S; Sekido M; Tjarks W; Fenstermaker RA; Ciesielski M; Nawrocky MM; Coderre JA Cancer Res; 2002 Jun; 62(11):3159-66. PubMed ID: 12036929 [TBL] [Abstract][Full Text] [Related]
12. Thermodynamic mixing of molecular states of the epidermal growth factor receptor modulates macroscopic ligand binding affinity. Holbrook MR; Slakey LL; Gross DJ Biochem J; 2000 Nov; 352 Pt 1(Pt 1):99-108. PubMed ID: 11062062 [TBL] [Abstract][Full Text] [Related]
13. Conjugate chemistry, iodination and cellular binding of mEGF-dextran-tyrosine: preclinical tests in preparation for clinical trials. Zhao Q; Blomquist E; Bolander H; Gedda L; Hartvig P; Janson J; Lundqvist H; Mellstedt H; Nilsson S; Nistèr M; Sundin A; Tolmachev V; Westlin J; Carlsson J Int J Mol Med; 1998 Apr; 1(4):693-702. PubMed ID: 9852284 [TBL] [Abstract][Full Text] [Related]
14. Binding of 125I after administration of 125I-EGF-dextran, 125I-EGF or 125I to human bladder cancer spheroids. Sjöström A; Bue P; Malmstrom P; Carlsson J Int J Oncol; 2000 Sep; 17(3):559-64. PubMed ID: 10938398 [TBL] [Abstract][Full Text] [Related]
15. Retention of biologic activity of human epidermal growth factor following conjugation to a blood-brain barrier drug delivery vector via an extended poly(ethylene glycol) linker. Deguchi Y; Kurihara A; Pardridge WM Bioconjug Chem; 1999; 10(1):32-7. PubMed ID: 9893961 [TBL] [Abstract][Full Text] [Related]
16. Cellular uptake of radioiodine delivered by trastuzumab can be modified by the addition of epidermal growth factor. Nordberg E; Steffen AC; Persson M; Sundberg AL; Carlsson J; Glimelius B Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):771-7. PubMed ID: 15765233 [TBL] [Abstract][Full Text] [Related]